PL2817286T3 - Inhibitory kinazy do leczenia raka - Google Patents
Inhibitory kinazy do leczenia rakaInfo
- Publication number
- PL2817286T3 PL2817286T3 PL13764613T PL13764613T PL2817286T3 PL 2817286 T3 PL2817286 T3 PL 2817286T3 PL 13764613 T PL13764613 T PL 13764613T PL 13764613 T PL13764613 T PL 13764613T PL 2817286 T3 PL2817286 T3 PL 2817286T3
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- treatment
- kinase inhibitors
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012901199A AU2012901199A0 (en) | 2012-03-23 | Kinase inhibitors for the Treatment of Cancer | |
| PCT/AU2013/000290 WO2013138863A1 (en) | 2012-03-23 | 2013-03-22 | Kinase inhibitors for the treatment of cancer |
| EP13764613.9A EP2817286B1 (en) | 2012-03-23 | 2013-03-22 | Kinase inhibitors for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2817286T3 true PL2817286T3 (pl) | 2018-11-30 |
Family
ID=49221707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13764613T PL2817286T3 (pl) | 2012-03-23 | 2013-03-22 | Inhibitory kinazy do leczenia raka |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9308193B2 (pl) |
| EP (2) | EP3061451B1 (pl) |
| JP (2) | JP6165231B2 (pl) |
| KR (1) | KR102055176B1 (pl) |
| CN (2) | CN105534969B (pl) |
| AU (2) | AU2013234869B2 (pl) |
| CA (1) | CA2868120C (pl) |
| ES (2) | ES2732229T3 (pl) |
| HK (1) | HK1223832A1 (pl) |
| NZ (2) | NZ630807A (pl) |
| PL (1) | PL2817286T3 (pl) |
| WO (1) | WO2013138863A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2757598T3 (es) * | 2012-08-06 | 2020-04-29 | Pitney Pharmaceuticals Pty Ltd | Compuestos para el tratamiento de las enfermedades relacionadas con la vía mTOR |
| US9833431B2 (en) | 2013-11-01 | 2017-12-05 | Pitney Pharmaceuticals Pty Limited | Pharmaceutical combinations for the treatment of cancer |
| WO2016137010A1 (en) * | 2015-02-24 | 2016-09-01 | Nihon Nohyaku Co., Ltd. | Anti cancer agent comprising aminoacetonitrile compound as active ingredient |
| JP7697690B2 (ja) * | 2020-03-04 | 2025-06-24 | 国立大学法人山口大学 | 新規なフルオロアルカン誘導体及びそれらを用いたゲル化剤 |
| CA3183094A1 (en) * | 2020-05-11 | 2021-11-18 | Pitney Pharmaceuticals Pty Limited | Use of aminoacetonitrile compounds for the treatment of infection and disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4584305A (en) * | 1972-08-17 | 1986-04-22 | Janssen Pharmaceutica N.V. | Aiding the regression of neoplastic disease with 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AT408615B (de) | 1998-09-15 | 2002-01-25 | Immuno Ag | Neue influenzavirus-impfstoffzusammensetzung |
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| AR036054A1 (es) * | 2001-06-15 | 2004-08-04 | Novartis Ag | Uso de compuestos de aminoacetonitrilo para el control de plagas, una composicion y un proceso para dicho control y una composicion farmaceutica contra parasitos |
| GB0402677D0 (en) * | 2003-11-06 | 2004-03-10 | Novartis Ag | Organic compounds |
| AR049391A1 (es) * | 2004-06-10 | 2006-07-26 | Novartis Ag | Derivados de aminoacetonitrilo y su uso para controlar parasitos en animales de sangre caliente |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| CN102127074A (zh) | 2010-12-17 | 2011-07-20 | 中国药科大学 | 6-氨磺酰基取代-β-咔啉-1-酮类细胞周期蛋白依赖性激酶2抑制剂及其用途 |
-
2013
- 2013-03-22 CA CA2868120A patent/CA2868120C/en active Active
- 2013-03-22 US US14/387,270 patent/US9308193B2/en active Active
- 2013-03-22 NZ NZ630807A patent/NZ630807A/en unknown
- 2013-03-22 AU AU2013234869A patent/AU2013234869B2/en active Active
- 2013-03-22 WO PCT/AU2013/000290 patent/WO2013138863A1/en not_active Ceased
- 2013-03-22 KR KR1020147029526A patent/KR102055176B1/ko active Active
- 2013-03-22 CN CN201610041111.6A patent/CN105534969B/zh not_active Expired - Fee Related
- 2013-03-22 JP JP2015500717A patent/JP6165231B2/ja active Active
- 2013-03-22 EP EP16162192.5A patent/EP3061451B1/en active Active
- 2013-03-22 CN CN201380024851.3A patent/CN104364232B/zh active Active
- 2013-03-22 EP EP13764613.9A patent/EP2817286B1/en active Active
- 2013-03-22 PL PL13764613T patent/PL2817286T3/pl unknown
- 2013-03-22 ES ES16162192T patent/ES2732229T3/es active Active
- 2013-03-22 ES ES13764613.9T patent/ES2685612T3/es active Active
- 2013-03-22 NZ NZ714625A patent/NZ714625A/en not_active IP Right Cessation
-
2015
- 2015-06-19 HK HK16112097.9A patent/HK1223832A1/en unknown
-
2016
- 2016-03-01 US US15/057,628 patent/US20160220527A1/en not_active Abandoned
- 2016-06-27 AU AU2016204389A patent/AU2016204389B2/en not_active Ceased
-
2017
- 2017-02-28 JP JP2017036116A patent/JP6483736B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HK1223832A1 (en) | 2017-08-11 |
| CA2868120C (en) | 2019-02-19 |
| HK1205500A1 (en) | 2015-12-18 |
| NZ630807A (en) | 2016-04-29 |
| JP6483736B2 (ja) | 2019-03-13 |
| JP2017125041A (ja) | 2017-07-20 |
| CN105534969B (zh) | 2019-04-05 |
| KR20140145604A (ko) | 2014-12-23 |
| EP3061451A1 (en) | 2016-08-31 |
| NZ714625A (en) | 2017-02-24 |
| EP2817286A1 (en) | 2014-12-31 |
| AU2013234869B2 (en) | 2016-06-30 |
| US9308193B2 (en) | 2016-04-12 |
| US20150051290A1 (en) | 2015-02-19 |
| AU2013234869A1 (en) | 2014-10-02 |
| KR102055176B1 (ko) | 2019-12-12 |
| WO2013138863A1 (en) | 2013-09-26 |
| CN104364232A (zh) | 2015-02-18 |
| CA2868120A1 (en) | 2013-09-26 |
| AU2016204389B2 (en) | 2018-01-25 |
| JP2015510898A (ja) | 2015-04-13 |
| EP2817286A4 (en) | 2015-09-02 |
| JP6165231B2 (ja) | 2017-07-19 |
| ES2732229T3 (es) | 2019-11-21 |
| CN104364232B (zh) | 2017-05-31 |
| AU2016204389A1 (en) | 2016-07-14 |
| US20160220527A1 (en) | 2016-08-04 |
| CN105534969A (zh) | 2016-05-04 |
| EP3061451B1 (en) | 2019-05-08 |
| ES2685612T3 (es) | 2018-10-10 |
| EP2817286B1 (en) | 2018-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274318A (en) | Cancer treatment with rapamycin target site kinase inhibitors | |
| PT3418281T (pt) | Pirazolo[1,5-a]pirimidinas úteis como inibidores da quinase atr para o tratamento de doenças de cancro | |
| IL232128B (en) | Tor kinase inhibitors for cancer treatment | |
| IL235726A0 (en) | Pyrimidine compounds for cancer treatment | |
| IL238400A0 (en) | Triazolopyrazines as brd4 inhibitors for use in cancer therapy | |
| IL241232A0 (en) | Cancer treatment agents | |
| IL234639B (en) | Cancer treatment with rapamycin target site kinase inhibitors | |
| ZA201406706B (en) | Treatment of cancer with tor kinase inhibitors | |
| EP2968348A4 (en) | COMPOUNDS FOR THE TREATMENT OF CANCER | |
| IL234641A0 (en) | Cancer treatment with rapamycin target site kinase inhibitors | |
| ZA201409194B (en) | Biflourodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders | |
| ZA201503105B (en) | Treatment of prostate cancer with tor kinase inhibitors | |
| AP2015008532A0 (en) | Syk kinase inhibitors as treatment for malaria | |
| PL2817286T3 (pl) | Inhibitory kinazy do leczenia raka | |
| IL234686B (en) | Methods of treating cancer by using Aurora Kinase inhibitors | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| AU2012901199A0 (en) | Kinase inhibitors for the Treatment of Cancer | |
| ZA201502294B (en) | Treatment of cancer with tor kinase inhibitors |